Paraneoplastic neurological syndromes associated with non-Hodgkin lymphoma: a case series

2022 ◽  
Author(s):  
Alessandro Dinoto ◽  
Marta Cheli ◽  
Mauro Catalan ◽  
Sasha Olivo ◽  
Ilario Scali ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Case Series ◽  
Paraneoplastic Neurological Syndromes ◽  
Non Hodgkin Lymphoma

AML-448: Overlapping B-Cell Non-Hodgkin Lymphoma with Myeloid Malignancies: A Case Series

2021 ◽  
Vol 21 ◽  
pp. S313
Author(s):  
Ayman Youssef ◽  
Mohamed Badreldein ◽  
Ashraf Elghandour ◽  
Sara Eshba ◽  
Reem Eshra
Keyword(s):  
B Cell ◽  
Hodgkin Lymphoma ◽  
Case Series ◽  
Myeloid Malignancies ◽  
Non Hodgkin Lymphoma

scholarly journals Obstructive Jaundice as an Initial Manifestation of Non-Hodgkin Lymphoma: Treatment Dilemma and High Mortality

2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
Dhara Chaudhari ◽  
Sarah Khan ◽  
Atif Saleem ◽  
Tamarro Taylor ◽  
Chakradhar Reddy ◽  
...  
Keyword(s):  
Obstructive Jaundice ◽  
Hodgkin Lymphoma ◽  
High Mortality ◽  
Biliary Obstruction ◽  
Multiorgan Failure ◽  
Case Series ◽  
Initial Manifestation ◽  
Ct Guided ◽  
Non Hodgkin Lymphoma ◽  
Lymphoma Treatment

Introduction. Non Hodgkin lymphoma (NHL) presenting with obstructive jaundice is a rare occurrence. Because of rarity of combination, it is seldom considered in differential diagnosis of patients presenting with obstructive jaundice. It is considered treatable due to the chemosensitive nature of the disease and the recent advances in chemotherapy.Case Series. We present a case series of 2 patients with NHL presenting with obstructive jaundice as an initial manifestation. Both patients presented with obstructive jaundice and were diagnosed by CT guided liver biopsy. One patient died of sepsis and multiorgan failure before initiating chemotherapy and the second patient did not choose to undergo chemotherapy.Conclusion. Biliary obstruction is a sign of poor prognosis. The diagnosis of NHL needs to be considered in patients presenting with biliary obstruction. It can be associated with high mortality and poses treatment dilemma.

scholarly journals Different mucosal presentations of non-Hodgkin lymphoma: case series

Mucosa ◽  
2020 ◽  
Vol 3 (3) ◽  
pp. 69-74
Author(s):  
Ayşenur BAHADIR ◽  
Murat ÇAKIR ◽  
Elif SAĞ ◽  
Gökçe Pınar REİS ◽  
İ̇lker EYÜPOĞLU ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Case Series ◽  
Non Hodgkin Lymphoma

Palifermin as primary mucositis prophylaxis in patients with B-cell Non-Hodgkin lymphoma: a case series

2021 ◽  
pp. 1-3
Author(s):  
Anthony S. Zembillas ◽  
Stefanie M. Thomas ◽  
Seth J. Rotz ◽  
Ilia N. Buhtoiarov ◽  
Rabi Hanna
Keyword(s):  
B Cell ◽  
Hodgkin Lymphoma ◽  
Case Series ◽  
Non Hodgkin Lymphoma

scholarly journals Do the acute lymphoblastic leukemia and non-hodgkin lymphoma patients have a worse prognosis of COVID-19 infection in children?: a case report

2021 ◽  
Vol 12 (1) ◽  
pp. 20-25
Author(s):  
Nadirah Rasyid Ridha ◽  
Bahrul Fikri ◽  
Rahmawaty Rahimi ◽  
Amiruddin Laompo ◽  
Conny Tanjung ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Severe Acute Respiratory Syndrome ◽  
Hodgkin Lymphoma ◽  
Lymphoblastic Leukemia ◽  
Case Series ◽  
Case Presentation ◽  
Non Hodgkin Lymphoma ◽  
Pediatric Cancer Patients ◽  
New Type ◽  
Worse Prognosis

Background: Coronavirus Disease 2019 (COVID-19) is a contagious disease caused by a new type of Coronavirus namely Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Children with tumors or autoimmune diseases are more susceptible, because of suppression of their immune system, chemotherapy, radiotherapy, or surgery on tumors. Case presentation: We present the clinical features 3 Acute Lymphoblastic leukemia and 1 Non-Hodgkin lymphoma patients who were infected with COVID-19 since July to August 2020 in our hospital. These were the first four cases identified as COVID-19 positive in Dr Wahidin Sudirohusodo Hospital. Case 1, 2, and 4 were diagnosed as moderate and common type of COVID-19, while case 3 was classified as severe type. They may be transmitted COVID-19 infection during hospitalization. All cases were recovered from COVID-19 after a combination therapy against virus, bacteria, and also respiratory support. Conclusion: Our case series of four pediatric cancer patients showed a good outcome after prompt treatment, suggesting that malignancy in children may not be a contributor factor for COVID-19 recovery. Keywords: COVID-19; acute lymphoblastic leukemia; non-hodgkin lymphoma; children   Abstrak Latar belakang: Covid-19 (Coronavirus disease 2019) adalah penyakit menular yang disebabkan oleh Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Anak yang menderita kanker atau penyakit autoimun lebih rentan tertular karena penurunan system kekebalan tubuh, dampak kemoterapi, radioterapi, atau operasi tumor. Penyajian kasus: Kami melaporkan 3 pasien leukemia limfoblastik akut  dan 1 pasien limfoma non-Hodgkin yang terinfeksi Covid-19 sejak Juli-Agustus 2020. Kasus tersebut adalah 4 kasus pertama yang teridentifikasi Covid-19 di Rumah Sakit Dr. Wahidin Sudirohusodo. Kasus 1,2, dan 4 terdiagnosis positif Covid -19 derajat sedang, sedangkan kasus 3 tergolong berat. Mereka kemungkinan terinfeksi Covid-19 saat perawatan. Semua kasus dinyatakan sembuh dari Covid-19 setelah pemberian obat anti virus, antibiotik, dan alat bantu pernapasan. Kesimpulan: Serial kasus dari 4 pasien kanker anak dengan outcome yang baik setelah pengobatan yang cepat mengindikasikan bahwa penyakit keganasan pada anak kemungkinan bukan faktor yang berkontribusi dalam kesembuhan Covid-19. Kata kunci:  COVID-19; leukemia limfoblastik akut; limfoma non-hodgkin; anak    

scholarly journals THE CLINICOPATHOLOGICAL PATTERN OF TESTICULAR TUMORS A 3-YEARS EXPERIENCE AT A TERTIARY CARE UROLOGY CENTER

2021 ◽  
Vol 71 (2) ◽  
pp. 517-21
Author(s):  
Badar Murtaza ◽  
Muhammad Rafiq Zafar ◽  
Zahoor Iqbal Mirza ◽  
Muhammad Akmal ◽  
Hussain Ahmad ◽  
...  
Keyword(s):  
Germ Cell ◽  
Hodgkin Lymphoma ◽  
Clinical Presentation ◽  
Operative Procedure ◽  
Tertiary Care ◽  
Germ Cell Tumors ◽  
Case Series ◽  
Armed Forces ◽  
Testicular Tumors ◽  
Non Hodgkin Lymphoma

Objective: To evaluate the clinical presentation of testicular tumors and their histological pattern present in our setup. Study Design: Case series. Place and Duration of Study: Armed Forces Institute of Urology (AFIU) Rawalpindi, from Jul 2016 to Jun 2019. Methodology: The documents of all the cases of testicular tumors presenting in the last 3 years were retrieved and their relevant clinical detail: age, clinical presentation, side of involvement, operative procedure conducted and the histopathology report were documented. Results: Thirty two patients of testicular tumors were documented over a period of three years, making 10.66 cases reporting per year. The mean age was 30.10 ± 15.42 years, with the youngest 3 months old infant and the eldest being 58 years of age. The tumors were commonest on the right (59.3%) with 81.2% presentation as swelling of testis. Radical orchiectomy was performed in 90.6% of the cases and retro peritoneal lymph node dissection (RPLND) in 6.2%. Germ cell tumors were found in 71.8% cases with mixed germ cell tumorbeing the commonest histopathology seen in 31.2% of the cases followed by the seminoma (25%) and non-Hodgkin lymphoma (12.5%). Conclusion: Testicular tumors were relatively uncommon in our part of the world with a limited number of cases presenting to a tertiary care urology center. The presentation was variable but a rising trend in non-Hodgkin lymphoma results in a decrease in the overall number of germ cell tumors.

Enteroviral infection in patients treated with rituximab for non-Hodgkin lymphoma: a case series and review of the literature

2016 ◽  
Vol 35 (4) ◽  
pp. 591-598 ◽  
Author(s):  
S. Grisariu ◽  
I. Vaxman ◽  
M. Gatt ◽  
S. Elias ◽  
B. Avni ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Case Series ◽  
Review Of The Literature ◽  
Enteroviral Infection ◽  
Non Hodgkin Lymphoma
Sign in / Sign up

Export Citation Format

Share Document